Baxion
Screening
Tags
Alerts
Theme
Rigel Pharmaceuticals Inc.
RIGL
·
NASDAQ
·
$29.17
Share Price as of 11/2
·
$540M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/04/26
10-Q
Q1 ended 03/31/26
05/05/26
10-K
FY 2025
03/03/26
10-Q
Q3 ended 09/30/25
11/04/25
10-Q
Q2 ended 06/30/25
08/05/25
Disclosures
Filter
8-K
Current report
08/04/26
8-K
Current report
07/01/26
8-K
Current report
06/17/26
8-K
Current report
05/20/26
8-K
Current report
05/12/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
08/04/26
S-8
Registration of securities for employees
08/06/25
S-8
Registration of securities for employees
08/06/24
S-3
Shelf registration
08/02/24
S-8
Registration of securities for employees
08/01/23
Proxies
Filter
DEF 14A
Definitive proxy
04/03/26
DEFA14A
Additional proxy materials
04/03/26
DEF 14A
Definitive proxy
04/10/25
DEFA14A
Additional proxy materials
04/10/25
DEF 14A
Definitive proxy
04/10/24
Ownership
Filter
Form 4
Insider transaction
09/03/26
Form 4
Insider transaction
09/03/26
Form 4
Insider transaction
09/03/26
Form 4
Insider transaction
09/03/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Other
Filter
ARS
Annual report to shareholders
04/10/25
EFFECT
Request for effectiveness
08/09/24
CORRESP
Correspondence with the SEC
08/08/24
UPLOAD
Letter from the SEC
08/07/24
ARS
Annual report to shareholders
04/10/24
Latest Filings
Filter
10-Q
Q2 ended 06/30/26
08/04/26
8-K
Current report
08/04/26
S-8
Registration of securities for employees
08/04/26
8-K
Current report
07/01/26
8-K
Current report
06/17/26
Ownership
Filter
Form 4
Insider transaction
09/03/26
Form 4
Insider transaction
09/03/26
Form 4
Insider transaction
09/03/26
Form 4
Insider transaction
09/03/26
SC 13G/A
Beneficial ownership (amended)
08/14/26